✦ LIBER ✦

A randomized 4-arm multicenter study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C relapsing after interferon monotherapy

✍ Scribed by Giorgio Saracco; Alda Olivero; Alessia Ciancio; Silvia Carenzi; Antonina Smedile; Giuseppe Cariti; Massimo Andreoni; Pier Giulio Orsi; Alberto Biglino; Marco Tabone; Luigi Roffi; Guido Croce; Aldo Manca; Gianfranco Tappero; Giovannino Ciccone; Mario Rizzetto

Book ID: 111721975
Publisher: John Wiley and Sons
Year: 2002
Tongue: English
Weight: 119 KB
Volume: 36
Category: Article
ISSN: 0270-9139
DOI: 10.1053/jhep.2002.35442

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized 4-arm multicenter study of

A randomized 4-arm multicenter study of interferon alfa–2b plus ribavirin in the treatment of patients with chronic hepatitis C not responding to interferon alone

✍ Giorgio Saracco; Alessia Ciancio; Alda Olivero; Antonina Smedile; Luigi Roffi; G 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

Peginterferon alfa-2b plus ribavirin com

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

✍ Michael P Manns; John G McHutchison; Stuart C Gordon; Vinod K Rustgi; Mitchell S 📂 Article 📅 2001 🏛 The Lancet 🌐 English ⚖ 110 KB

Treatment of Chronic Hepatitis due to He

Treatment of Chronic Hepatitis due to Hepatitis C Virus (CH-C) in India: A Randomized Controlled Trial Comparing Daily Interferon-alfa-2b and Ribavirin with Daily Interferon-alfa-2b and Glycyrrhizin—A Multicenter Study

✍ Subrat K Acharya; V Sreenivas; Siddharth Datta Gupta; Shakti Kumar; Yogesh K Cha 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 186 KB

Pegylated α-interferon-2a plus ribavirin

Pegylated α-interferon-2a plus ribavirin compared with pegylated α-interferon-2b plus ribavirin for initial treatment of chronic hepatitis C virus: Prospective, non-randomized study

✍ Amparo Escudero; Felicidad Rodríguez; Miguel A Serra; Juan A Del Olmo; Francisco 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

Better efficacy of a 12-month interferon

Better efficacy of a 12-month interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-month treatment: A multicenter, controlled, randomized trial

✍ Jean-Louis Payen; Jacques Izopet; Virginie Galindo-Migeot; Valérie Lauwers-Cance 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 320 KB 👁 2 views

We studied the efficacy of three interferon alfa-2b (IFN-2b) regimens for the retreatment of patients with chronic hepatitis C (CHC) with prior complete response followed by relapse. Consecutive patients with CHC who had a complete biochemical response but relapse after a first course of 6 months of

Response to higher doses of interferon a

Response to higher doses of interferon alfa-2b in patients with chronic hepatitis C: A randomized multicenter trial

✍ K L Lindsay; G L Davis; E R Schiff; H C Bodenheimer; L A Balart; J L Dienstag; R 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 2 views

JANICE ALBRECHT, 12 AND THE HEPATITIS INTERVENTIONAL THERAPY GROUP\* with continued therapy at that dose; however, a propor-To evaluate response rates to 3, 5, or 10 million units tion of patients who do not respond to 12 weeks of treat-(MU) of interferon alfa-2b, given thrice weekly, and to ment wi